Brain Tumor Buzz

Antigenics (NASDAQ: AGEN) today announced that data from a multi-center Phase 1/2 clinical trial of Oncophage (vitespen) for recurrent high-grade glioma (brain cancer) was presented at the International Conference on Brain Tumor Research and Therapy. The study was conducted by the Brain Tumor Research Center at the University of California, San Francisco (UCSF).

Data from 32 evaluable patients suggest that vaccination with Oncophage may improve overall survival in patients with recurrent high-grade glioma. An overall median survival of 44 weeks after tumor resection was observed. Approximately 70% of the evaluable patients survived beyond 36 weeks, and 41% survived up to or longer than one year. This is considered a significant achievement in the treatment of recurrent high-grade glioma. In addition, Oncophage was well tolerated, with no serious adverse events attributable to the vaccine.

Viruses effective against brain cancer in animals: Human trials set to start

noreply@blogger.com (Crush) — Thu, 20 May 2010 20:10:00 +0000

Viruses effective against brain cancer in animals: Human trials set to start

Push to understand basis of childhood brain tumors leads to a new treatment target

noreply@blogger.com (Crush) — Thu, 20 May 2010 20:09:00 +0000

Push to understand basis of childhood brain tumors leads to a new treatment target

Generic drug may be potential treatment for deadly brain cancer

noreply@blogger.com (Crush) — Thu, 20 May 2010 20:07:00 +0000

Generic drug may be potential treatment for deadly brain cancer

Notch-blocking drugs kill brain cancer stem cells, yet multiple therapies may be needed

noreply@blogger.com (Crush) — Sat, 27 Feb 2010 21:13:00 +0000

February 26, 2010

Working with mice, Johns Hopkins scientists who tested drugs intended to halt growth of brain cancer stem cells - a small population of cells within tumors that perpetuate cancer growth - conclude that blocking these cells may be somewhat effective, but more than one targeted drug attack may be needed to get the job done.

One focus of attack is a chemical pathway within stem cells known as Notch, which scientists have shown is important for cancer stem cell growth. A new study published in the January 28 issue of Stem Cells by Charles Eberhart, M.D., Ph.D., associate professor of pathology, ophthalmology, and oncology at Johns Hopkins, now extends these findings to glioblastoma, the most common malignant brain tumor, and ultimately suggests other pathways and treatment with two or more drugs may need to be involved.

Eberhart based his conclusion on experiments in which he coaxed a glioblastoma cell line to form embryolike balls called neurospheres. Unlike most cells that will clump together in a culture dish, neurospheres - more organized groups of neural cells - can only form from stem cells. When Eberhart treated the neurospheres with a drug called GSI-18, which blocks the Notch pathway, the spheres were reduced by 70 percent or more. Eberhart also found that molecular markers typically found on the surface of brain cancer stem cells also plunged.

"This told us that the Notch pathway is a good target for drug development," says Eberhart, but further experiments suggested this approach may not be thorough enough.

In a second set of experiments, Eberhart collected the neurospheres that remained after treatment with the Notch-blocking drug and injected them into the brains of mice. The neurosphere transplants eventually grew into tumors and reignited the Notch pathway.

"This result suggested we didn't get rid of all the stem cells," says Eberhart, "so it's likely we may need to add more therapies or increase the dosage of Notch-blocking drugs."

The study by Eberhart identified additional molecular pathways, including Stat 3 and AKT, which are connected to Notch. He says that a combination of therapies blocking Notch and other pathways such as these could target brain cancer stem cells at several levels and possibly avoid drug resistance.

To test how a Notch-blocking drug worked in an animal model, Eberhart injected tumors into the brains of mice and let the cancer grow for two weeks. Then, at the tumor site, he implanted a polymer bead that was soaked in GSI-18. Five of six mice that received the drug-laden bead survived while all 12 that received a bead with no drug died.

Eberhart notes that Notch-targeting drugs can prove problematic in therapy because the Notch pathway is critically important for cells in the gut, helping cells there alternate between secreting mucus and absorbing nutrients. "A dosing regimen that preserves gut function has been developed, and forthcoming studies in humans will test whether it can kill the cancer stem cells."

Provided by Johns Hopkins Medical Institutions

Study: Brain cancer has four subtypes - Topix

noreply@blogger.com (Crush) — Wed, 10 Feb 2010 05:41:00 +0000

Study: Brain cancer has four subtypes - Topix

Researchers Say Coffee, Caffeine Slow Brain Cancer - Topix

noreply@blogger.com (Crush) — Wed, 10 Feb 2010 05:37:00 +0000

Researchers Say Coffee, Caffeine Slow Brain Cancer - Topix

Researchers Sequence Complete Genome Of Brain Cancer Cell Line - Topix

noreply@blogger.com (Crush) — Wed, 10 Feb 2010 05:36:00 +0000

Researchers Sequence Complete Genome Of Brain Cancer Cell Line - Topix

Two genes discovered that drive aggressive brain cancers

noreply@blogger.com (Crush) — Fri, 25 Dec 2009 04:05:00 +0000

Two genes discovered that drive aggressive brain cancers

The Dr. Oz tv show recap, episode 47: cell phones and brain cancer

noreply@blogger.com (Crush) — Thu, 19 Nov 2009 03:07:00 +0000

The Dr. Oz tv show recap, episode 47: cell phones and brain cancer

World's first delivery of intra-arterial Avastin directly into brain tumor

noreply@blogger.com (Crush) — Thu, 19 Nov 2009 03:04:00 +0000

World's first delivery of intra-arterial Avastin directly into brain tumor

Inside A Revolutionary Brain Cancer Treatment - Healthcare * US * News * Story - CNBC.com

noreply@blogger.com (Crush) — Thu, 19 Nov 2009 03:02:00 +0000

Inside A Revolutionary Brain Cancer Treatment - Healthcare * US * News * Story - CNBC.com

Breaching the Blood-Brain Barrier With Avastin to Fight Glioblastoma - NYTimes.com

noreply@blogger.com (Crush) — Thu, 19 Nov 2009 02:52:00 +0000

An experimental treatment for glioblastoma suppresses a barrier to deliver a drug directly to brain tumors.

Study: 7 genes predict brain cancer survival ï¿½ Abilene Reporter News

noreply@blogger.com (Crush) — Tue, 06 Oct 2009 00:43:00 +0000

Study: 7 genes predict brain cancer survival ï¿½ Abilene Reporter News

Shared via AddThis

Invasive Brain Cancer Studied - WauwatosaNow

noreply@blogger.com (Crush) — Wed, 23 Sep 2009 19:45:00 +0000

Invasive Brain Cancer Studied - WauwatosaNow

Shared via AddThis

Cottonseed extract may treat brain cancer like Kennedy's, Cancer Treatment

noreply@blogger.com (Crush) — Mon, 21 Sep 2009 02:39:00 +0000

Cottonseed extract may treat brain cancer like Kennedy's, Cancer Treatment

Shared via AddThis

Links for 2008-04-17 [del.icio.us]

Fri, 18 Apr 2008 00:00:00 PDT

Kaukauna mortgage firm plans expansion | Postcrescent.com | Appleton Post-Crescent

Links for 2008-02-01 [del.icio.us]

Sat, 02 Feb 2008 00:00:00 PST

Don’t Tell Prominent Duke Doctor that Cancer Can’t Be Cured

Links for 2008-01-24 [del.icio.us]

Fri, 25 Jan 2008 00:00:00 PST

Bond insurers rise on bailout hopes
Shares of bond insurers rose sharply Thursday on hopes the sector could receive support from a possible bailout orchestrated by New York insurance regulators.

Links for 2008-01-14 [del.icio.us]

Tue, 15 Jan 2008 00:00:00 PST

Romney and McCain turn up heat ahead of Michigan vote
By Andrew Stern DETROIT (Reuters) - Republicans Mitt Romney and John McCain turned up the heat on their bitter rivalry on Monday, trading charges over the economy and abortion on the eve of a critical showdown in Michigan's presidential...

Links for 2008-01-10 [del.icio.us]

Fri, 11 Jan 2008 00:00:00 PST

Bernanke On The Mortgage Crisis: A Curious Explanation

Links for 2008-01-09 [del.icio.us]

Thu, 10 Jan 2008 00:00:00 PST

Build Your Blog With Forum Traffic

Links for 2008-01-04 [del.icio.us]

Sat, 05 Jan 2008 00:00:00 PST

Option Arm Map